Skip to main content

Table 7 Comparison according to treatment modality (n = 63)

From: Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy

  

Local

treatment

Systemic

treatment

Both

treatments

P-value

Grade

1

2-3

Large

Small

14 (73.7%)

3 (15.8%)

1 (5.3%)

1 (5.3%)

7 (38.9%)

8 (44.4%)

3 (16.7%)

0 (O.0%)

13 (50.0%)

3 (11.5%)

5 (19.2%)

5 (19.2%)

.037

Metastatic site

Extrahepatic metastasis

Liver metastasis only

7 (33.3%)

14 (66.7%)

17 (77.3%)

5 (22.7%)

11 (52.4%)

10 (47.6%)

.015